These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Severity and outcomes of community acquired pneumonia in asthmatic patients. Terraneo S, Polverino E, Cilloniz C, Amaro R, Vennera Mdel C, Gabarrus A, Montull B, Moreno E, Menendez R, Centanni S, Torres A. Respir Med; 2014 Nov; 108(11):1713-22. PubMed ID: 25245791 [Abstract] [Full Text] [Related]
4. The effect of inhaled corticosteroids in the outcomes of community-acquired pneumonia: ICCAP study (TURKCAP Database). Baha A, Kokturk N, Bahcecioglu SN, Yapar D, Aksakal N, Gündüz C, Tasbakan S, Sayiner A, Coskun AS, Durmaz F, Cilli A, Celenk B, Kılınc O, Salman S, Hazar A, Tokgoz F. Clin Respir J; 2020 Apr; 14(4):397-404. PubMed ID: 31908143 [Abstract] [Full Text] [Related]
9. Relationship between the use of inhaled steroids for chronic respiratory diseases and early outcomes in community-acquired pneumonia. Almirall J, Bolíbar I, Serra-Prat M, Palomera E, Roig J, Hospital I, Carandell E, Agustí M, Ayuso P, Estela A, Torres A, Community-Acquired Pneumonia in Catalan Countries (PACAP). PLoS One; 2013 Dec 12; 8(9):e73271. PubMed ID: 24039899 [Abstract] [Full Text] [Related]
10. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD. Yamauchi Y, Yasunaga H, Hasegawa W, Sakamoto Y, Takeshima H, Jo T, Matsui H, Fushimi K, Nagase T. Int J Chron Obstruct Pulmon Dis; 2016 Dec 12; 11():1403-11. PubMed ID: 27382276 [Abstract] [Full Text] [Related]
11. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD. Crisafulli E, Menéndez R, Huerta A, Martinez R, Montull B, Clini E, Torres A. Chest; 2013 Apr 12; 143(4):1009-1017. PubMed ID: 23187314 [Abstract] [Full Text] [Related]
12. Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors. Ducharme FM, Noya FJ, Allen-Ramey FC, Maiese EM, Gingras J, Blais L. Curr Med Res Opin; 2012 Jan 12; 28(1):111-9. PubMed ID: 22077107 [Abstract] [Full Text] [Related]
13. Risk of pneumonia in asthmatic children using inhaled corticosteroids: a nested case-control study in a birth cohort. Shrestha P, Wi CI, Liu H, King KS, Ryu E, Kwon JH, Sohn S, Park M, Juhn Y. BMJ Open; 2022 Mar 10; 12(3):e051926. PubMed ID: 35273042 [Abstract] [Full Text] [Related]
14. Daily vs. intermittent inhaled corticosteroids for recurrent wheezing and mild persistent asthma: a systematic review with meta-analysis. Rodrigo GJ, Castro-Rodríguez JA. Respir Med; 2013 Aug 10; 107(8):1133-40. PubMed ID: 23769720 [Abstract] [Full Text] [Related]
17. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013. Cho KH, Kim YS, Linton JA, Nam CM, Choi Y, Park EC. Respir Med; 2017 Sep 10; 130():75-84. PubMed ID: 29206637 [Abstract] [Full Text] [Related]